Package 43063-744-30

Brand: bupropion hydrochloride sr

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 43063-744-30
Digits Only 4306374430
Product NDC 43063-744
Product ID 43063-744_414b455c-af7f-0fa9-e063-6294a90ac1af
Description

30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43063-744-30)

Marketing

Marketing Status
Marketed Since 2017-02-09
Brand bupropion hydrochloride sr
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

BUPROPION HYDROCHLORIDE SR ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "414b455c-af7f-0fa9-e063-6294a90ac1af", "openfda": {"upc": ["0343063744307"], "unii": ["ZG7E5POY8O"], "rxcui": ["993518"], "spl_set_id": ["f5d774dd-0f51-4a4f-a9d1-8b5f2364b1f7"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43063-744-30)", "package_ndc": "43063-744-30", "marketing_start_date": "20170209"}], "brand_name": "BUPROPION HYDROCHLORIDE SR", "product_id": "43063-744_414b455c-af7f-0fa9-e063-6294a90ac1af", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "43063-744", "generic_name": "Bupropion Hydrochloride", "labeler_name": "PD-Rx Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "brand_name_suffix": "SR", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA206674", "marketing_category": "ANDA", "marketing_start_date": "20160725", "listing_expiration_date": "20261231"}